<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Most leg <z:mpath ids='MPATH_579'>ulcers</z:mpath> occur in patients with <z:hpo ids='HP_0005293'>venous insufficiency</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, not <z:hpo ids='HP_0000001'>all</z:hpo> patients with <z:hpo ids='HP_0005293'>venous insufficiency</z:hpo> develop leg <z:mpath ids='MPATH_579'>ulcers</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Recent studies have found that factors causing clotting abnormalities, e.g. anticardiolipin antibody (ACA), are associated with leg <z:mpath ids='MPATH_579'>ulcers</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Although <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, like ACA, belongs to the group of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, its presence in patients with venous leg ulceration has not been previously reported </plain></SENT>
<SENT sid="4" pm="."><plain>OBJECTIVES: To determine the presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> in patients with venous leg ulceration </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: We investigated the presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> in 27 patients with venous leg <z:mpath ids='MPATH_579'>ulcers</z:mpath> and compared these data with controls </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> was evaluated in <z:hpo ids='HP_0000001'>all</z:hpo> subjects by the Russell's viper venom test </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Of 27 patients with venous leg ulceration, 16 (59%) were shown to have <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, while only one of 32 controls (3%) was found to have <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> was significantly more frequent in patients with venous leg <z:mpath ids='MPATH_579'>ulcers</z:mpath> than in controls (P &lt; 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: We suggest that <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> could be a hitherto unknown factor contributing to the development of venous leg <z:mpath ids='MPATH_579'>ulcers</z:mpath> </plain></SENT>
</text></document>